| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 10.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 20.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 25.0 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 80.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 100.0 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 100.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 75; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 160.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 200.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 75; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 90; 03/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with saline | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 75; 01/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 100.0 mg/kg/injection | 275.0 | Antitumor endpoint evaluated on day 85; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 100.0 mg/kg/injection | 283.0 | Antitumor endpoint evaluated on day 75; 09/09 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 200.0 mg/kg/injection | 275.0 | Antitumor endpoint evaluated on day 85; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 200.0 mg/kg/injection | 369.0 | Antitumor endpoint evaluated on day 75; 09/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 85; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | alkali diluted with water | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 75; 10/10 animals surviving on day 9 |